You're signed outSign in or to get full access.
Foresite Capital Management V, LLC
CIK:0001792206
Private Equity
$81M AUM
6 holdings
Larkspur, CA, USA
Foresite Capital is a multi-stage healthcare and life sciences investment firm addressing areas of great unmet need by funding promising businesses at all stages.
Latest 13F Filing Activity
Foresite Capital Management V, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 6 equity positions with a total 13F market value of $81M. The fund increased holdings in Hims & Hers Health, Inc., CG Oncology, Inc., Lyell Immunopharma Inc. among other positions. Foresite Capital Management V, LLC reduced exposure to Alumis Inc., Lyell Immunopharma Inc., Maze Therapeutics Inc. among others.
Top Buys
Top Holdings
Equity Positions (6)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
C CGON | CG Oncology, Inc. | 32.34% | $26.1M | 1,004,050 | $37.31 | $26.00 | +$5.1M |
A ALMS | Alumis Inc | 21.48% | $17.3M | 5,779,348 | $12.38 | $3.00 | -$18.1M |
I IRON | Disc Medicine, Inc. | 19.62% | $15.8M | 299,069 | $24.83 | $52.96 | +$992.9K |
H HIMS | Hims & Hers Health, Inc. | 16.87% | $13.6M | 273,151 | $7.70 | $49.85 | +$5.5M |
M MAZE | Maze Therapeutics Inc | 5.25% | $4.2M | 345,191 | $11.01 | $12.27 | +$434.9K |
Industry Allocation
PHARMACEUTICAL PREPARATIONS
+46.5%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+39.2%
BLANK CHECKS
+18.2%
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
+14.2%
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more